title: Deferral of routine booster doses of tetanus and diphtheria toxoids for adolescents and adults.
abstract: A shortage of tetanus and diphtheria toxoids (Td) and tetanus toxoid (TT) in the United States has resulted because one of two manufacturers discontinued production of tetanus toxoid-containing products. Aventis Pasteur (Swiftwater, Pennsylvania) is the only major manufacturer of tetanus and Td in the United States. In response to the shortage, Aventis Pasteur has increased production of Td to meet national needs; however, because 11 months are required for vaccine production, the shortage is expected to last for the remainder of 2001.
mesh_terms: D000293:Adolescent; D000328:Adult; D004168:Diphtheria Toxoid / Q000008:administration & dosage / Q000600:supply & distribution*; D006801:Humans; D007117:Immunization, Secondary; D013745:Tetanus Toxoid / Q000008:administration & dosage / Q000600:supply & distribution*; D014481:United States; D014611:Vaccination / Q000592:standards
chemical_list: D004168:Diphtheria Toxoid; D013745:Tetanus Toxoid